URINARY TRACT INFECTION CONTROL BEFORE PERCUTANEOUS NEPHROLITHOTOMY: MICROBIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES
Main Article Content
Abstract
Objectives: To describe the microbiological characteristics and infection-control outcomes of preoperative urinary tract infections in patients with kidney stones undergoing percutaneous nephrolithotomy (PCNL). Methods: A prospective, descriptive study was conducted on 41 patients with kidney stones complicated by lower urinary tract infection who underwent infection control before mini-PCNL at 108 Military Central Hospital from October 2024 to March 2025. Evaluated variables included microbiological cultures, systemic inflammatory response syndrome (SIRS), drainage methods, antibiotic treatment, and early postoperative infectious complications. Results: Lower urinary tract culture was positive in 33/41 patients (80.5%). Among 41 urinary isolates, Gram-negative bacteria predominated (78.0%); Escherichia coli (E. coli) accounted for 48.8% and Pseudomonas aeruginosa (P. aeruginosa) accounted for 14.6%. SIRS was recorded in 18/41 patients (43.9%). Percutaneous nephrostomy was performed in 20/41 patients (48.8%). Among 21 patients initially treated with empirical antibiotics, 13 regimens were concordant with antimicrobial susceptibility testing (61.9%). The mean duration of antibiotic therapy was 8.98 ± 4.01 days. Postoperative fever occurred in 3/41 patients (7.3%); no postoperative sepsis or septic shock was recorded. Conclusion: Preoperative urinary tract infection before PCNL was mainly caused by Gram-negative bacteria. Antibiotic therapy combined with decompressive drainage when indicated controlled infection before surgery and contributed to a low rate of early postoperative infectious complications.
Keywords
Urinary tract infection, Percutaneous nephrolithotomy, Antibiotics, Infection control, Bacteria
Article Details
References
2. Bonkat G, Bartoletti R, Bruyère F, et al. EAU Guidelines on Urological Infections. EAU Guidelines Office; 2025. Accessed May 24, 2026. https://uroweb.org/ guidelines/urological-infections
3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology and antimicrobial resistance. Nat Rev Microbiol. 2015;13(5):269-84. doi:10.1038/nrmicro3432
4. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86. doi:10.1128/CMR.18.4.657-686.2005
5. Pearle MS, Pierce HL, Miller GL, et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol. 1998;160(4):1260-4. doi:10.1016/ S0022-5347(01) 62511-4
6. Tambo M, Okegawa T, Shishido T, et al. Predictors of septic shock in obstructive acute pyelonephritis. World J Urol. 2014;32(3):803-11. doi:10.1007/s00345- 013-1166-4
7. Bộ Y tế. Hướng dẫn sử dụng kháng sinh. Ban hành kèm theo Quyết định số 708/QĐ-BYT ngày 02 tháng 3 năm 2015. Hà Nội, Việt Nam. 2015.
8. Zhou G, Zhou Y, Chen R, et al. The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2023;51(1):17. doi: 10.1007/ s00240-022-01376-5